KN
KIDRON NADAV Chairman & CEO
C-suite M
US US · SEC (Form 4)
Discover the complete record of transactions filed by KIDRON NADAV, Chairman & CEO. Insider active across 1 companies, notably Oramed Pharmaceuticals INC.. In total, 16 filings have been recorded. Total volume traded: €15.1m. The latest transaction was filed on 28 December 2021 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations 16 total
150,000 shares
Common Stock
SEC:0001213900-22-001613 · 3 Jan 2022
150,000 shares
Common Stock
SEC:0001213900-22-001613:0 · 3 Jan 2022
150,000 shares
Common Stock
SEC:0001213900-22-000818:0 · 3 Jan 2022
150,000 shares
Common Stock
SEC:0001213900-22-000818 · 3 Jan 2022
€363,485 31,728 shares @ €11.4563 4.6% of flow
Common Stock
SEC:0001213900-21-068231 · 28 Dec 2021
€363,485 31,728 shares @ €11.4563 0.32% mcap 2.3% of flow
Common Stock
SEC:0001213900-21-068231:0 · 28 Dec 2021
100,000 shares
Common Stock
SEC:0001213900-21-063944 · 31 Aug 2021
€4m 220,000 shares @ €17.1276 47.7% of flow
Common Stock
SEC:0001213900-21-063945 · 9 Aug 2021
20,000 shares
Common Stock
SEC:0001213900-21-063983 · 3 Dec 2021
20,000 shares
Common Stock
SEC:0001213900-21-063983:0 · 3 Dec 2021
100,000 shares
Common Stock
SEC:0001213900-21-063944:0 · 31 Aug 2021
€4m 220,000 shares @ €17.1276 3.37% mcap 23.8% of flow
Common Stock
SEC:0001213900-21-063945:0 · 9 Aug 2021
100,000 shares
Common Stock
SEC:0001213900-21-046407 · 31 Aug 2021
100,000 shares
Common Stock
SEC:0001213900-21-046407:0 · 31 Aug 2021
€4m 220,000 shares @ €17.1276 47.7% of flow
Common Stock
SEC:0001213900-21-041711 · 9 Aug 2021
€4m 220,000 shares @ €17.1276 3.37% mcap 23.8% of flow
Common Stock
SEC:0001213900-21-041711:0 · 9 Aug 2021
About KIDRON NADAV Nadav Kidron is an executive at Oramed Pharmaceuticals Inc.